CanNordic a/s: Financial statements 2020
CVR: 33871902
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
CanNordic a/s (CVR 33871902) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 775,497 and a net result of DKK -46,451 compared with DKK -177,679 the year before. That is an increase of 267.3% compared with the year before. Equity in the 2020 report amounted to DKK 46,773. The solvency ratio was 0.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 775,497
- Profit/Loss
- DKK -46,451
- Equity
- DKK 46,773
- Total Assets
- DKK 5,511,742
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 775 t. | -46 t. | 47 t. | 2 |
| 2019 | - | 211 t. | -178 t. | -1.8 mio. | - |
| 2018 | - | 579 t. | 200 t. | -1.6 mio. | - |
| 2017 | - | -417 t. | -571 t. | -1.8 mio. | - |
| 2016 | - | -383 t. | -803 t. | -1.3 mio. | - |
Official annual report
How creditworthy is CanNordic a/s?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CanNordic a/s has published its annual report for 2019. Gross profit came to DKK 211,131, and the net result was DKK -177,679.
As of February 27, 2020, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of CanNordic a/s.
As of February 27, 2020, Pryds Statsautoriseret Revisionsfirma has stepped down as auditor of CanNordic a/s.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.